Literature DB >> 33539238

Community nurses' support for patients with fibromyalgia who use cannabis to manage pain.

Natasha J Andrews1, Adele J Phillips2.   

Abstract

Supporting patients to manage chronic pain conditions, such as fibromyalgia (FM), remains a challenge for community nurses. Research suggests that despite the absence of a licensed cannabis-based product for medicinal use (CBPM) available for people with FM in the UK, there is an appetite for FM patients to use cannabis for pain management. Nurses have expressed anxieties when balancing tensions between helping patients and working within medical guidelines, as well as a need for further education about patient cannabis use. This article provides community nurses with insight into how cannabis use affects the pain experience for people living with FM. Despite potential harms, cannabis is perceived by users to have a positive impact on the lived experience of pain, and it may be preferred to prescribed opioid medication. This understanding can help to inform empathic practice and recommendations are made for reducing the risks of cannabis use to patient health.

Entities:  

Keywords:  Cannabis; Community nursing; Fibromyalgia; Harm reduction; Lived experience; Pain

Mesh:

Substances:

Year:  2021        PMID: 33539238     DOI: 10.12968/bjcn.2021.26.2.92

Source DB:  PubMed          Journal:  Br J Community Nurs        ISSN: 1462-4753


  2 in total

Review 1.  The State of the Evidence about the Family and Community Nurse: A Systematic Review.

Authors:  Federica Dellafiore; Rosario Caruso; Michela Cossu; Sara Russo; Irene Baroni; Serena Barello; Ida Vangone; Marta Acampora; Gianluca Conte; Arianna Magon; Alessandro Stievano; Cristina Arrigoni
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

2.  Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users.

Authors:  Jolanta Chmielowiec; Krzysztof Chmielowiec; Jolanta Masiak; Tomasz Pawłowski; Dariusz Larysz; Anna Grzywacz
Journal:  Genes (Basel)       Date:  2021-12-10       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.